Anonymous ID: 3829e6 Feb. 25, 2022, 11:27 a.m. No.15721528   🗄️.is 🔗kun

>>15721235

Today, the Russian Ministry of Defense (MoD) is reporting:

 

“The Russian military has not launched any missiles at Kiev and over 150 Ukrainian military personal have surrendered”

 

“Russian military forces have successfully captured the Hostomel airfield near Ukraine’s capital, Kiev”

 

“Air strikes by the Russian military destroyed 74 military infrastructure targets of the Ukrainian armed forces…Among them are 11 airfields, three command centres, a Ukrainian Navy post, 18 S-300 radars (NATO reporting name SA-10 Grumble), and Buk (NATO reporting name Gadfly) air defence systems of the Ukrainian military…Russian forces shot down a Ukrainian attack helicopter and four Turkish-made Bayraktar strike drones in the Donbass region”

 

“Forty-one Ukrainian military vehicles, 18 tanks and armoured fighting vehicles, 7 multiple rocket systems, and 5 combat boats have been destroyed by Russian forces”

 

“Yesterday, on 24 February, units of the Russian Airborne Forces took full control of the territory in the area of the Chernobyl nuclear power plant…An agreement was reached with the servicemen of a separate battalion protecting the nuclear power plant of Ukraine on joint security of the power units and the sarcophagus of the Chernobyl NPP”

 

“A Ukrainian military airplane went down near Kiev…The plane was carrying 14 people in total and all fatalities were caused by a fire that started after the plane crash landed”

 

“An An-26 aircraft of the Russian Aerospace Forces crashed during a scheduled flight to transport military equipment…The plane’s crew was killed on impact”

 

https://sputniknews.com/20220225/day-2-of-russian-special-op-live-updates-donetsk-resident-wounded-by-ukrainian-shelling-dpr-says-1093353535.html

https://www.rt.com/russia/550616-russia-captures-kiev-airfield/

https://sputniknews.com/20220224/russian-air-strikes-destroy-74-ukrainian-military-infrastructure-targets-ministry-of-defence-says-1093335308.html

https://www.rt.com/russia/550537-military-cargo-aircraft-crash/

Anonymous ID: 3829e6 Feb. 25, 2022, 11:57 a.m. No.15721809   🗄️.is 🔗kun   >>1820 >>1849 >>1856 >>1919 >>1929

>>15721684

>Trying to try ivermectin, and not overdose

WHY? do you HAVE the covid? or parasites? otherwise, DON'T. it's NOT for prophylaxis. it is a serious drug that can have serious potentially fatal side effects. it is to be used ONLY to fight an active infection, and only until the infection is cured.

Anonymous ID: 3829e6 Feb. 25, 2022, 12:13 p.m. No.15721945   🗄️.is 🔗kun

>>15721820

 

RESULTS

 

A total of 1,668 reports for ivermectin were identified. The most commonly reported adverse events for ivermectin were pruritus (25.3%), headache (13.9%), and dizziness (7.5%). Under the MedDRA SOC “Neurological disorders,” there were a total of 426 reports; 156 of these were classified as “serious” according to ICH Guidance.14 Of the serious reports, 60.9% (95) originated from Africa, 20.5% (32) from the Americas, 12.2% (19) from Europe, and 6.4% (10) from Asia. One duplicate report was identified and excluded from the analysis.

 

Sixty-four of the 155 serious reports described the use of ivermectin for O. volvulus. Forty-two reports did not include an indication; one reported only “infection parasitic.” The remaining 48 reports underwent clinical review, and twenty reports were further excluded from this analysis. Reasons for exclusion were neurological adverse events reported in the context of other clinical syndromes (lactic acidosis/circulatory collapse, cerebral infarction/cerebral artery embolism, neuroleptic malignant syndrome, hepatitis/hepatic failure, brain cancer, pneumonia with hypotension, accidental exposure to product, sepsis complicating chemotherapy, multi-organ failure, history of epilepsy, and Alzheimer’s disease), topical ivermectin for rosacea, prolonged time to onset of events in comparison with the known half-life of ivermectin (14 days and 8 years), and unclear onset of symptoms in relation to ivermectin.

 

The remaining 28 reports are included in this case series (Table 1). The cases were received from the United States, France, Japan, the Netherlands, Germany, Canada, and Sierra Leone. The patient ages were included in 25 reports and ranged from 11 to 97 years. Fourteen reports described adverse events in males, 13 in females, and the gender was not provided in one report. Scabies was included as an indication in 10 reports, acarodermatitis (within the MedDRA terminology, acarodermatitis may be used to indicate any of the following terms: acarodermatitis, Norwegian scabies, Sarcoptes scabeii infestation, scabies, and scabies infestation) in eight, filariasis due to Wucheria bancrofti in five, strongyloidiasis in three, teniasis in one, and myiasis in one. The time to onset of the serious neurological events ranged from hours to 7 days, with 14 cases noting a time to onset of 1 day or less. Examples of serious neurological adverse events reported included such terms as unable to walk, consciousness disturbed or depressed level of consciousness or loss of consciousness, seizure or convulsion, encephalopathy or coma, and tremor. The reported dosages of ivermectin ranged between 3 and 24 mg. Most of the cases reported a one-time dose or two doses separated by 1 week. Weight information was provided for most of the cases, and there was no suggestion of overdose based on the data provided. Nine reports documented a positive dechallenge, with resolution of symptoms after discontinuing ivermectin without further intervention. Three reports documented a positive rechallenge, with recurrence of symptoms with re-exposure to ivermectin, including one case with repeated symptoms on three separate treatment courses with ivermectin. Concomitant medications were reported in 20 cases. In nine of the cases, the drugs co-administered with ivermectin were also reported to be “suspected” for the described adverse drug reactions, including oxatomide, piperonyl butoxide/esdepallethrime (topical), darunavir and ritonavir, terbinafine, and albendazole. Eight cases reported concomitant drugs with known CNS effects, including antidepressants, antipsychotics, benzodiazepines, and anticonvulsants; however, in none of these cases were the concomitant CNS-acting agents considered to be “suspected.”

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929173/